🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
307,02 USD
Máx. histórico
322,75
3 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-4,87%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-4,87%
Cierre anterior
322,75
Rango de hoy
306,17 – 324,95
Volumen hoy
265.433
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 32,35 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 1 día
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/08/2025 | 158,00 | 161,93 | 156,91 | 159,08 | +1,13% | 3,18% | 234.100 |
| 21/08/2025 | 155,51 | 157,91 | 154,91 | 157,31 | +1,33% | 1,93% | 95.400 |
| 20/08/2025 | 154,56 | 156,67 | 152,23 | 155,25 | +0,77% | 2,87% | 153.900 |
| 19/08/2025 | 153,20 | 154,17 | 151,59 | 154,07 | +0,53% | 1,68% | 113.200 |
| 18/08/2025 | 150,89 | 154,89 | 149,51 | 153,26 | +1,44% | 3,57% | 204.100 |
| 15/08/2025 | 155,28 | 155,28 | 150,89 | 151,08 | -1,76% | 2,83% | 245.400 |
| 14/08/2025 | 153,26 | 155,07 | 151,46 | 153,79 | -1,42% | 2,36% | 203.300 |
| 13/08/2025 | 152,80 | 157,54 | 151,24 | 156,01 | +2,17% | 4,12% | 352.300 |
| 12/08/2025 | 150,00 | 156,53 | 149,00 | 152,69 | +3,86% | 5,02% | 1.767.900 |
| 11/08/2025 | 138,37 | 148,17 | 137,14 | 147,01 | -2,03% | 7,97% | 1.082.200 |
| 08/08/2025 | 148,26 | 151,55 | 143,51 | 150,06 | +2,56% | 5,42% | 195.500 |
| 07/08/2025 | 144,80 | 149,21 | 140,00 | 146,32 | +2,75% | 6,36% | 300.200 |
| 06/08/2025 | 134,08 | 143,79 | 132,21 | 142,40 | +5,36% | 8,64% | 300.500 |
| 05/08/2025 | 135,43 | 135,88 | 132,70 | 135,15 | -0,18% | 2,35% | 185.800 |
| 04/08/2025 | 133,18 | 135,39 | 131,67 | 135,39 | +2,01% | 2,79% | 103.500 |
| 01/08/2025 | 131,00 | 133,19 | 129,55 | 132,72 | +0,87% | 2,78% | 156.000 |
| 31/07/2025 | 133,72 | 137,25 | 131,12 | 131,58 | -2,70% | 4,58% | 227.700 |
| 30/07/2025 | 133,85 | 138,02 | 133,85 | 135,23 | +2,77% | 3,12% | 181.700 |
| 29/07/2025 | 135,86 | 136,12 | 131,57 | 131,58 | -2,48% | 3,35% | 100.900 |
| 28/07/2025 | 135,32 | 135,58 | 133,62 | 134,92 | -0,67% | 1,45% | 118.800 |
| 25/07/2025 | 133,62 | 135,83 | 132,59 | 135,83 | +2,26% | 2,42% | 124.900 |
| 24/07/2025 | 136,10 | 137,00 | 132,72 | 132,83 | -2,48% | 3,14% | 91.800 |
| 23/07/2025 | 133,89 | 137,39 | 133,13 | 136,21 | +2,83% | 3,18% | 157.500 |
| 22/07/2025 | 142,00 | 142,30 | 131,75 | 132,46 | -6,14% | 7,43% | 238.500 |
| 21/07/2025 | 138,68 | 143,13 | 137,37 | 141,12 | +1,45% | 4,15% | 427.600 |
| 18/07/2025 | 138,12 | 139,71 | 135,24 | 139,10 | +1,11% | 3,24% | 347.100 |
| 17/07/2025 | 129,47 | 137,84 | 129,47 | 137,57 | +6,13% | 6,46% | 371.300 |
| 16/07/2025 | 125,30 | 130,94 | 123,66 | 129,63 | +4,29% | 5,81% | 290.700 |
| 15/07/2025 | 127,12 | 127,17 | 122,29 | 124,30 | -2,06% | 3,84% | 180.300 |
| 14/07/2025 | 120,68 | 127,07 | 120,68 | 126,92 | +4,29% | 5,29% | 140.900 |